C1QTNF6 and nasopharyngeal carcinoma: More recently, in nasopharyngeal carcinoma (NPC), N6-methyladenosine (m6A)-hypomethylated CTRP6 was shown to promote radio resistance by stabilizing mitochondria-associated membranes (MAMs) and inhibiting ferroptosis [52].